Literature DB >> 25637530

Optical imaging of COX-2: studies on an autofluorescent 2,3-diaryl-substituted indole-based cyclooxygenase-2 inhibitor.

Christoph Tondera1, Sandra Ullm1, Markus Laube1, Sebastian Meister2, Christin Neuber2, Birgit Mosch2, Torsten Kniess2, Jens Pietzsch3.   

Abstract

This study aimed at in vivo visualization of cyclooxygenase-2 (COX-2) by optical imaging using a representative compound of a class of autofluorescent 2,3-diaryl-substituted indole-based selective COX-2 inhibitors (2,3-diaryl-indole coxibs). COX-2 was successfully visualized in mice models with phorbol myristate ester (TPA)-induced inflammation or bearing xenografted human melanoma cells by 2-[4-(aminosulfonyl)phenyl]-3-(4-methoxyphenyl)-1H-indole (C1). COX-2 protein expression in both TPA-induced inflammatory sites and human melanoma xenografts was confirmed by immunoblotting. Control experiments using surrogate markers, sham injections, and non-COX-2 expressing melanoma cells further confirmed specificity of tissue association of C1. The merging of therapeutic and diagnostic properties of 2,3-diaryl-indole coxibs may widen the range of applications of COX-2-targeted treatment, e.g., for in situ-guided surgery and ex vivo diagnostics.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fluorescence; Luminescence; Melanoma-associated inflammation; Phorbol myristate ester-induced COX-2 expression; Rodent melanoma xenograft model

Mesh:

Substances:

Year:  2015        PMID: 25637530     DOI: 10.1016/j.bbrc.2015.01.057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Bifunctional conjugates with potent inhibitory activity towards cyclooxygenase and histone deacetylase.

Authors:  Idris Raji; Fatima Yadudu; Emily Janeira; Shaghayegh Fathi; Lindsey Szymczak; James Richard Kornacki; Kensei Komatsu; Jian-Dong Li; Milan Mrksich; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2016-12-24       Impact factor: 3.641

Review 2.  Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review.

Authors:  Markus Laube; Torsten Kniess; Jens Pietzsch
Journal:  Antioxidants (Basel)       Date:  2016-04-19

3.  Sulindac, a non-steroidal anti-inflammatory drug, mediates breast cancer inhibition as an immune modulator.

Authors:  Tao Yin; Guoping Wang; Tinghong Ye; Yongsheng Wang
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379

4.  Synthesis and Cyclooxygenase Inhibition of Sulfonamide-Substituted (Dihydro)Pyrrolo[3,2,1-hi]indoles and Their Potential Prodrugs.

Authors:  Markus Laube; Cemena Gassner; Torsten Kniess; Jens Pietzsch
Journal:  Molecules       Date:  2019-10-22       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.